08045804946
Send Inquiry
LEUPROMAK 11.25MG INJ
2800.0 INR/Number
Product Details:
- Dosage Form Lyophilized powder for injection
- Pacakaging (Quantity Per Box) 1 vial + 1 ampoule + instructions
- Indication Treatment of hormone-responsive cancers and conditions.
- Origin of Medicine India
- Salt Composition Leuprolide Acetate
- Life Span 36 months from manufacture
- Packaging Type Vial with solvent ampoule, sterile
- Click to View more
X
LEUPROMAK 11.25MG INJ Price And Quantity
- 1 Number
- 2800.0 INR/Number
LEUPROMAK 11.25MG INJ Product Specifications
- Prescription Only, Hormonal therapy
- Leuprolide Acetate
- India
- Treatment of hormone-responsive cancers and conditions.
- Gonadotropin-Releasing Hormone (GnRH) Analog. Suppresses hormone production.
- Leuprolide Acetate
- 1 Vial
- Adults
- 1 vial + 1 ampoule + instructions
- Lyophilized powder for injection
- Prostate Cancer, Endometriosis, Uterine Fibroids, Precocious Puberty
- Administer as an intramuscular injection under medical supervision
- Vial with solvent ampoule, sterile
- 36 months from manufacture
- Store below 25C. Protect from light. Do not freeze.
- 11.25 mg every 3 months (as directed by physician)
- Injection
- Yes
- Hot flashes, headache, mood swings, injection site reactions
- Intramuscular injection
- Reconstitute with provided sterile solvent before use
- Not for use in pregnant or breastfeeding women, hypersensitivity to leuprolide
- WHO-GMP certified manufacturer
- White to off-white lyophilized powder
- To be administered only by a qualified health professional
- Antineoplastic and Endocrine Therapy
LEUPROMAK 11.25MG INJ Trade Information
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
- Active Ingredient: Leuprolide acetate 11.25 mg.
- Mechanism: It is a synthetic hormone that initially stimulates, then suppresses, the pituitary gland's release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), ultimately reducing the production of testosterone in men and estrogen in women.
- Administration: It is a depot (long-acting) formulation administered as a single intramuscular injection by a healthcare professional, typically every three months. It is not for self-administration.
Uses
Leupromak 11.25 mg is used to treat several hormone-dependent conditions:
- Prostate cancer: Manages advanced prostate cancer symptoms by slowing the growth of cancer cells dependent on testosterone.
- Endometriosis: Helps reduce estrogen levels, which alleviates pain and other symptoms by shrinking abnormal uterine-like tissue growing outside the uterus.
- Uterine fibroids: Used to reduce the size of non-cancerous growths in the uterus and manage associated anemia and heavy bleeding.
How Does LEUPROMAK 11.25MG INJ Work?
LEUPROMAK contains Leuprolide Acetate, a GnRH analog that suppresses the production of hormones responsible for the progression of certain cancers and reproductive disorders. Through this hormone suppression, LEUPROMAK helps control the growth or activity of hormone-responsive tissues, providing symptom relief.
What is the Recommended Dosage and Administration Process?
The standard dosage of LEUPROMAK is 11.25 mg administered every three months. The vial contains a lyophilized powder, which must be reconstituted with the supplied sterile solvent by a qualified healthcare provider. The medication is then given as a slow intramuscular injection. Self-injection is not advised.
Who Should Not Use LEUPROMAK?
LEUPROMAK is contraindicated in pregnant or breastfeeding women, as well as individuals with known hypersensitivity to leuprolide or any of the formulation components. It is strictly for adult use and must be prescribed and supervised by a healthcare provider.
Storage and Handling Instructions
Store LEUPROMAK below 25C, protected from light, and do not freeze. Each box includes one vial of powder, a sterile solvent ampoule, and administration guidelines. Handle and prepare the injection only in a clinical setting to maintain sterility and efficacy.
FAQ's of LEUPROMAK 11.25MG INJ:
Q: How should LEUPROMAK 11.25MG INJ be prepared and administered?
A: LEUPROMAK should be reconstituted with the provided sterile solvent and administered as an intramuscular injection by a qualified health professional. It is not for self-administration.Q: What conditions is LEUPROMAK 11.25MG INJ recommended to treat?
A: LEUPROMAK is recommended for hormone-responsive conditions such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty in adults.Q: When should LEUPROMAK 11.25MG INJ not be used?
A: This injection should not be used by pregnant or breastfeeding women, or by individuals allergic to leuprolide or any other formulation ingredient.Q: Where should LEUPROMAK 11.25MG INJ be stored?
A: Store the medication below 25C, protected from light, and do not freeze. Keep it in its original packaging until ready to use.Q: What are some possible side effects experienced with LEUPROMAK?
A: Possible adverse effects include hot flashes, headaches, mood swings, and local injection site reactions. Consult your doctor if side effects persist or worsen.Q: How often is LEUPROMAK 11.25MG INJ administered?
A: LEUPROMAK is typically administered once every three months, as directed by the prescribing physician.Q: What are the benefits of LEUPROMAK in hormone-responsive conditions?
A: LEUPROMAK effectively suppresses hormone production, which helps manage symptoms and slow disease progression in hormone-dependent cancers and reproductive disorders.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
